Search Results | American Association for Cancer Research

1-20 of 1100

2 3 4 5

Sort by

Sort Order Select

Journal Articles

Optimized Systematic Review Tool: Application to Candidate Biomarkers for the Diagnosis of Hepatocellular Carcinoma

Mei Ran Abellona U, Eric Yi-Liang Shen, Caroline Cartlidge, Alzhraa Alkhatib, Mark R. Thursz, Imam Waked, Asmaa I. Gomaa, Elaine Holmes, Rohini Sharma, Simon D. Taylor-Robinson

Cancer Epidemiol Biomarkers Prev (2022) 31 (7): 1261–1274.

DOI: https://doi.org/10.1158/1055-9965.EPI-21-0687

Published: 01 July 2022

View article

Includes: Supplementary data

Journal Articles

The Impact of Morbidity and Disability on Attendance at Organized Breast Cancer–Screening Programs: A Systematic Review and Meta-Analysis

Lorna McWilliams, Samantha Groves, Sacha J. Howell, David P. French

Cancer Epidemiol Biomarkers Prev (2022) 31 (7): 1275–1283.

DOI: https://doi.org/10.1158/1055-9965.EPI-21-1386

Published: 01 July 2022

View article

Includes: Supplementary data

Journal Articles

Forkhead Box Transcription Factors: Double-Edged Swords in Cancer

Maria Castaneda, Petra den Hollander, Sendurai A. Mani

Cancer Res (2022) 82 (11): 2057–2065.

DOI: https://doi.org/10.1158/0008-5472.CAN-21-3371

Published: 06 June 2022

View article

Journal Articles

Epigenetic and Transcriptional Regulation of Innate Immunity in Cancer

Chuan Chen, Na Man, Fan Liu, Gloria Mas Martin, Hidehiro Itonaga, Jun Sun, Stephen D. Nimer

Cancer Res (2022) 82 (11): 2047–2056.

DOI: https://doi.org/10.1158/0008-5472.CAN-21-3503

Published: 06 June 2022

View article

Journal Articles

The Genetic Evolution of Metastasis

Aljosja Rogiers, Irene Lobon, Lavinia Spain, Samra Turajlic

Cancer Res (2022) 82 (10): 1849–1857.

DOI: https://doi.org/10.1158/0008-5472.CAN-21-3863

Published: 16 May 2022

View article

Journal Articles

Pathophysiologic and Pharmacologic Considerations to Improve the Design and Application of Antibody–Drug Conjugates

Erwin R. Boghaert, Megan C. Cox, Kedar S. Vaidya

Cancer Res (2022) 82 (10): 1858–1869.

DOI: https://doi.org/10.1158/0008-5472.CAN-21-3236

Published: 16 May 2022

View article

Journal Articles

Cancer Epidemiology in Hispanic Populations: What Have We Learned and Where Do We Need to Make Progress?

Laura Fejerman, Amelie G. Ramirez, Anna María Nápoles, Scarlett Lin Gomez, Mariana C. Stern

Cancer Epidemiol Biomarkers Prev (2022) 31 (5): 932–941.

DOI: https://doi.org/10.1158/1055-9965.EPI-21-1303

Published: 04 May 2022

View article

Journal Articles

A Review of Ethical and Legal Aspects of Gender-Neutral Human Papillomavirus Vaccination

Margaret Logel, Cassandra Laurie, Mariam El-Zein, Juliet Guichon, Eduardo L. Franco

Cancer Epidemiol Biomarkers Prev (2022) 31 (5): 919–931.

DOI: https://doi.org/10.1158/1055-9965.EPI-21-1256

Published: 04 May 2022

View article

Includes: Supplementary data

Journal Articles

Targeting Stearoyl-CoA Desaturase in Solid Tumors

Casie S. Kubota, Peter J. Espenshade

Cancer Res (2022) 82 (9): 1682–1688.

DOI: https://doi.org/10.1158/0008-5472.CAN-21-4044

Published: 03 May 2022

View article

Journal Articles

Exploiting LRRC15 as a Novel Therapeutic Target in Cancer

Upasana Ray, Christopher L. Pathoulas, Prabhu Thirusangu, James W. Purcell, Nagarajan Kannan, Viji Shridhar

Cancer Res (2022) 82 (9): 1675–1681.

DOI: https://doi.org/10.1158/0008-5472.CAN-21-3734

Published: 03 May 2022

View article

Journal Articles

Adapted to Survive: Targeting Cancer Cells with BH3 Mimetics

Joan Montero, Rizwan Haq

Cancer Discov (2022) 12 (5): 1217–1232.

DOI: https://doi.org/10.1158/2159-8290.CD-21-1334

Published: 02 May 2022

View article

Journal Articles

Tumor Immune Microenvironment of Brain Metastases: Toward Unlocking Antitumor Immunity

Matthew R. Strickland, Christopher Alvarez-Breckenridge, Justin F. Gainor, Priscilla K. Brastianos

Cancer Discov (2022) 12 (5): 1199–1216.

DOI: https://doi.org/10.1158/2159-8290.CD-21-0976

Published: 02 May 2022

View article

Journal Articles

Few, but Efficient: The Role of Mast Cells in Breast Cancer and Other Solid Tumors

Maria Teresa Majorini, Mario Paolo Colombo, Daniele Lecis

Cancer Res (2022) 82 (8): 1439–1447.

DOI: https://doi.org/10.1158/0008-5472.CAN-21-3424

Published: 15 April 2022

View article

Journal Articles

Understanding Drug Sensitivity and Tackling Resistance in Cancer

Jeffrey W. Tyner, Franziska Haderk, Anbarasu Kumaraswamy, Linda B. Baughn, Brian Van Ness, Song Liu, Himangi Marathe, Joshi J. Alumkal, Trever G. Bivona, Keith Syson Chan, Brian J. Druker, Alan D. Hutson, Peter S. Nelson, Charles L. Sawyers, Christopher D. Willey

Cancer Res (2022) 82 (8): 1448–1460.

DOI: https://doi.org/10.1158/0008-5472.CAN-21-3695

Published: 15 April 2022

View article

Journal Articles

A Structure is Worth a Thousand Words: New Insights for RAS and RAF Regulation

Dhirendra K. Simanshu, Deborah K. Morrison

Cancer Discov (2022) 12 (4): 899–912.

DOI: https://doi.org/10.1158/2159-8290.CD-21-1494

Published: 01 April 2022

View article

Journal Articles

Expanding the Reach of Precision Oncology by Drugging All KRAS Mutants

Marco H. Hofmann, Daniel Gerlach, Sandra Misale, Mark Petronczki, Norbert Kraut

Cancer Discov (2022) 12 (4): 924–937.

DOI: https://doi.org/10.1158/2159-8290.CD-21-1331

Published: 01 April 2022

View article

Includes: Supplementary data

Journal Articles

Classification of KRAS-Activating Mutations and the Implications for Therapeutic Intervention

Christian Johnson, Deborah L. Burkhart, Kevin M. Haigis

Cancer Discov (2022) 12 (4): 913–923.

DOI: https://doi.org/10.1158/2159-8290.CD-22-0035

Published: 01 April 2022

View article

Journal Articles

Facts and Hopes in Prediction, Diagnosis, and Treatment of Immune-Related Adverse Events

James W. Smithy, David M. Faleck, Michael A. Postow

Clin Cancer Res (2022) 28 (7): 1250–1257.

DOI: https://doi.org/10.1158/1078-0432.CCR-21-1240

Published: 01 April 2022

View article

Journal Articles

IFNγ Signaling in Natural and Therapy-Induced Antitumor Responses

Alex Martínez-Sabadell, Enrique J. Arenas, Joaquín Arribas

Clin Cancer Res (2022) 28 (7): 1243–1249.

DOI: https://doi.org/10.1158/1078-0432.CCR-21-3226

Published: 01 April 2022

View article

Journal Articles

Independent Drug Action in Combination Therapy: Implications for Precision Oncology

Deborah Plana, Adam C. Palmer, Peter K. Sorger

Cancer Discov (2022) 12 (3): 606–624.

DOI: https://doi.org/10.1158/2159-8290.CD-21-0212

Published: 08 March 2022

View article

Includes: Supplementary data

2 3 4 5

NARROW

Optimized Systematic Review Tool: Application to Candidate Biomarkers for the Diagnosis of Hepatocellular Carcinoma

The Impact of Morbidity and Disability on Attendance at Organized Breast Cancer–Screening Programs: A Systematic Review and Meta-Analysis

Forkhead Box Transcription Factors: Double-Edged Swords in Cancer

Epigenetic and Transcriptional Regulation of Innate Immunity in Cancer

The Genetic Evolution of Metastasis

Pathophysiologic and Pharmacologic Considerations to Improve the Design and Application of Antibody–Drug Conjugates

Cancer Epidemiology in Hispanic Populations: What Have We Learned and Where Do We Need to Make Progress?

A Review of Ethical and Legal Aspects of Gender-Neutral Human Papillomavirus Vaccination

Targeting Stearoyl-CoA Desaturase in Solid Tumors

Exploiting LRRC15 as a Novel Therapeutic Target in Cancer

Adapted to Survive: Targeting Cancer Cells with BH3 Mimetics

Tumor Immune Microenvironment of Brain Metastases: Toward Unlocking Antitumor Immunity

Few, but Efficient: The Role of Mast Cells in Breast Cancer and Other Solid Tumors

Understanding Drug Sensitivity and Tackling Resistance in Cancer

A Structure is Worth a Thousand Words: New Insights for RAS and RAF Regulation

Expanding the Reach of Precision Oncology by Drugging All KRAS Mutants

Classification of KRAS-Activating Mutations and the Implications for Therapeutic Intervention

Facts and Hopes in Prediction, Diagnosis, and Treatment of Immune-Related Adverse Events

IFNγ Signaling in Natural and Therapy-Induced Antitumor Responses

Independent Drug Action in Combination Therapy: Implications for Precision Oncology

AACR Journals

AACR Journals

This Feature Is Available To Subscribers Only